Learn More
Medchemexpress LLC BSJ-04-132 | 2349356-39-2 | 99.1% | C42H49N11O7 | 10MG

Supplier: Medchemexpress LLC HY13625210MG
BSJ-04-132 is a Ribociclib-based PROTAC designed to induce selective degradation of cyclin-dependent kinase 4 (CDK4) through cereblon recruitment. It is supplied as a high-purity research reagent for biochemical and cell-based studies of CDK4 regulation and targeted protein degradation mechanisms.
- Selective CDK4 degrader suitable for mechanistic studies.
- Designed to recruit cereblon for ubiquitin-proteasome degradation.
- High stated purity for reproducible experimental results.
- Available in small-mg packaging for research use.
- Compatible with biochemical and cell-based assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.